Danazol in acquired amegakaryocytic thrombocytopenic purpura: a case report.
Acquired amegakaryocytic thrombocytopenic purpura is a rare disease. Most reported patients did not respond to any therapeutical approach. Recently we observed a striking improvement of this disorder in a female patient shortly after therapy with danazol had been initiated. This observation and its possible implication for the treatment of amegakaryocytic thrombocytopenia are reported herein.
D000328:Adult; D001853:Bone Marrow / Q000473:pathology; D003613:Danazol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010976:Platelet Count / Q000187:drug effects; D011245:Pregnadienes / Q000627:therapeutic use*; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy* / Q000473:pathology
D011245:Pregnadienes; D003613:Danazol